about
Biomarkers of progression of chronic obstructive pulmonary disease (COPD)Personalizing and targeting therapy for COPD: the role of molecular and clinical biomarkers.How microRNAs orchestrate the lung's biological responses.The effect of diesel emission exposure on primary human bronchial epithelial cells from a COPD cohort: N-acetylcysteine as a potential protective interventionPersonalised multidisciplinary management for patients with chronic obstructive pulmonary disease (COPD)COPD and the gut-lung axis: the therapeutic potential of fibreNutritional support in chronic obstructive pulmonary disease (COPD): an evidence updatePrimary human bronchial epithelial cell responses to diesel and biodiesel emissions at an air-liquid interfaceCRISPR-Cas9 technology: A new direction for personalized medicine in respiratory disease?The cytotoxic, inflammatory and oxidative potential of coconut oil-substituted diesel emissions on bronchial epithelial cells at an air-liquid interface
P50
Q26996356-10D25687-6159-49D6-BD1B-529756A2217BQ38155607-94113E76-A191-4E2C-85C8-26A37ED102F8Q47906856-15BDBC05-61EF-401A-AC3F-9F17BC3AF417Q90778210-C3CD4AEE-6BDE-4FEF-8EDF-E9D034CB64A6Q91318329-561FF9BA-64B2-443D-B56F-24DB322A84EEQ91318345-60D85117-6707-4D45-9AF4-C3BC1729AC90Q91318364-04C7DE15-5F1E-4574-BC7F-52623E26B679Q91436820-C96C3296-F62E-47AF-8E4A-5969F89D3BC0Q91593082-D63CF5E3-62A0-40B9-9B52-D6EE46645486Q92161909-C0F25893-C2D8-413A-B046-0E52168578BA
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Annalicia Vaughan
@en
Annalicia Vaughan
@nl
type
label
Annalicia Vaughan
@en
Annalicia Vaughan
@nl
prefLabel
Annalicia Vaughan
@en
Annalicia Vaughan
@nl
P31
P496
0000-0001-5890-7877